期刊
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
卷 37, 期 10, 页码 2207-2218出版社
SPRINGER
DOI: 10.1007/s00384-022-04255-y
关键词
Rectal cancer; Neoadjuvant chemoradiotherapy; Lateral lymph node dissection; Total mesorectal excision
资金
- Ministry of Education, Culture, Sports, Science and Technology of Japan
This study analyzed the recurrence patterns of rectal cancer and found that pelvic cavity recurrence was associated with cCRM, distant recurrence with cN positivity, and LPLN recurrence with pretreatment LPLN swelling, lower tumor location, and higher serum CEA level. Patients without cCRM and swollen LPLN had very low local recurrence rates even if they underwent TME alone.
Purpose For rectal cancer, a multimodality approach is mandatory including neoadjuvant chemoradiotherapy, neoadjuvant chemotherapy, and lateral pelvic lymph node (LPLN) dissection, in addition to the total mesorectal excision (TME). However, these treatments are associated with adverse events. It is important to select patients who do or do not need these treatments. Methods We retrospectively analyzed patients with cStage II and III rectal cancer who underwent curative resection at three hospitals. Recurrence patterns were classified into three types; pelvic cavity, LPLN, and distant recurrences, and the risk factors for each pattern of recurrence were compared. We then analyzed the risk of recurrence in the patients who underwent TME alone. Results In total, 506 patients were enrolled in this study. Pelvic cavity recurrence was significantly associated with clinical assumption of circumferential resection margin involvement (cCRM) (p < 0.001), distant recurrence was associated with cN positivity (p < 0.001), and LPLN recurrence was associated with pretreatment LPLN swelling >= 5 mm (p < 0.001), lower tumor location (p = 0.016), and serum CEA level > 5 ng/mL (p = 0.008). In patients without cCRM and swollen LPLN, the local recurrence rate was extremely low even if they underwent TME alone; the 5-year recurrence rates of pelvic cavity and LPLN were 2.2% and 1.9%, respectively. Conclusion Additional treatments to TME for rectal cancer need to be performed based on the risk factors for each recurrence pattern.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据